Sen. Rand Paul (R-KY) said a committee-approved resolution to hold Dr. Anthony Fauci in contempt will be referred to the Justice Department [1, 2, 3].
The move marks a significant escalation in the ongoing conflict between Republican lawmakers and the former public health official over the U.S. government's handling of the COVID-19 pandemic. It signals a shift from legislative inquiry to potential criminal referral.
The Senate Homeland Security and Governmental Affairs Committee took the vote on Thursday, Aug. 5 [2, 3]. Paul, who chairs the committee, said that the referral from the party-line vote would be delivered to the attorney general on Aug. 6 [2].
Republican senators allege that Dr. Fauci repeatedly invoked the Fifth Amendment and refused to answer critical questions regarding the federal COVID-19 response [4, 5]. This refusal to provide testimony prompted the committee to move forward with the contempt-of-Congress resolution [4, 5].
While the resolution is headed to the Justice Department, Paul said that the committee has not exhausted all its options. He noted that the matter could still be brought before the full Senate for further action [1].
"We will forward it. It's the committee's verdict that he should be held in contempt, and it will be sent," Paul said. "But no one said that we won't bring it before the Senate" [1].
The committee's action follows a series of contentious hearings where lawmakers questioned the origins of the pandemic, and the efficacy of lockdown measures. The referral to the Justice Department is the primary mechanism for Congress to seek legal penalties for witnesses who refuse to comply with subpoenas or congressional inquiries.
“It's the committee's verdict that he should be held in contempt, and it will be sent.”
This referral represents a formal attempt by a Republican-led Senate committee to penalize a former official for non-compliance with legislative oversight. While the Justice Department holds the discretion on whether to pursue criminal charges, the action increases political pressure on the executive branch and ensures the debate over the federal COVID-19 response remains a focal point of congressional scrutiny.
